Domain Therapeutics' Grant - III Round

Domain Therapeutics raised a round of funding on April 14, 2014. Investors include The Michael J. Fox Foundation.

Domain Therapeutics, formerly Faust Pharmaceuticals, is a biopharmaceutical company dedicated to the discovery and early development of small molecules targeting G-Protein Coupled Receptors (GPCRs). D…

Articles about Domain Therapeutics' Grant - III Round: